Speakers

Expand/Collapse

A. Stewart Campbell
CEO | Head of R&D
Axial Therapeutics Inc

Day Two

Thursday October 15, 2020

3:45 pm | Q&A and Discussion Panel

2:55 pm | Disruptive Approaches to Treat CNS Diseases via the Gut-Brain Axis (GBA)

Aaron B. Cowley, Ph.D.
Chief Scientific Officer
Arranta Bio

Day One

Wednesday October 14, 2020

10:00 am | Things to Consider as You Transverse from Discovery to Product Development

Andrew A. Bremer
Chief, Pediatric Growth & Nutrition Branch
NICHD/NIH

Day One

Wednesday October 14, 2020

1:30 pm | Panel: Determining Ideal Breastmilk Composition: What is the Gold Standard of Gold Standards

Day Two

Thursday October 15, 2020

4:50 pm | Final Q&A and Discussion Panel

4:00 pm | Working With the NIH to Advance the Science

Anita Kozyrskyj
Research Chair & Professor – Pediatrics,
University of Alberta

Day Two

Thursday October 15, 2020

12:50 pm | Q&A and Extended Metabolic Disease Discussion Panel

12:25 pm | Intervention in Early-Life Microbiota Pathways to prevent Chronic Disease: A Birth Cohort Analysis

Boris Kramer
Director of Pediatric Research
Maastricht University Medical Center

Day Two

Thursday October 15, 2020

2:30 pm | The Gut-Brain-Axis in Preterm Babies - The Final Proof for All the Animal Work?

3:45 pm | Q&A and Discussion Panel

12:50 pm | Q&A and Extended Metabolic Disease Discussion Panel

Camilia Martin
Associate Professor of Pediatrics
Harvard Medical School

Day One

Wednesday October 14, 2020

3:50 pm | Afternoon Q&A and Panel

5:25 pm | Chair’s Closing remarks

2:35 pm | Human Milk Composition: Informing the Maternal-Infant Interface and Molecular Pathways in Preterm Infant Health and Disease

1:30 pm | Panel: Determining Ideal Breastmilk Composition: What is the Gold Standard of Gold Standards

8:20 am | Chair’s Opening Remarks

Christian Diener
Research Scientist
Institute for Systems Biology

Day Two

Thursday October 15, 2020

5:50 pm | Q&A and Discussion Panel

5:00 pm | Using Computational Models to Predict Personalized Intervention Effects in the Gut Microbiome

Christopher Stewart
Research Fellow and Group Leader
Newcastle University

Day One

Wednesday October 14, 2020

3:50 pm | Afternoon Q&A and Panel

2:10 pm | Breast Milk and Gut Microbiome in Term and Preterm Infants

1:30 pm | Panel: Determining Ideal Breastmilk Composition: What is the Gold Standard of Gold Standards

Clémentine Trotin-Picolo
Technical Director
TargEDys

Day Two

Thursday October 15, 2020

9:45 am | Morning Q&A and Discussion Panel

8:30 am | New Probiotic Approach to Optimize Children’s Growth by Increasing the Amino Acid Absorption

Darren Smith
Professor of Bacteriophage Biology
Northumbria University

Day Two

Thursday October 15, 2020

10:40 am | The Antibiotic Problem: Current and Future Opportunities When Treating Infants In the NICU

David Kyle
Chairman & CEO
Evolve Biosystems, Chair

Dr. Kyle, a 35-year veteran of biotechnology has co-founded biotech companies in the field of infant nutrition including Martek Biosciences. At Martek, he led R&D and Commercial Development for over 15 years and today Martek’s DHA and ARA are now found in virtually every infant formula around the world. In 2000 he co-founded the US Chapter of the Mother and Child Foundation, an organization headquartered in London dedicated to better health of pregnant women and their children through better nutrition.  In 2013, David joined Evolve BioSystems as CEO and led the Company through several private equity financings and became Chairman of the Board and CSO in 2017.  David combines a distinguished scientific background with commercial acumen, has published over 70 scientific articles, edited two books, is the named inventor on over 200 patents, and was inducted into the US Technology Hall of Fame in 2009, for his contributions to Science and Industry.

Day Two

Thursday October 15, 2020

9:45 am | Morning Q&A and Discussion Panel

8:55 am | Precision Nutrition and the Importance of the Infant Gut Microbiome in the NICU 

David Sela
Associate Professor
University of Massachusetts

Day One

Wednesday October 14, 2020

5:15 pm | Wrap up Q&A and Panel

4:50 pm | Human Milk Non-Protein Nitrogen Influences Microbiome Function Within the Infant Gut

1:30 pm | Panel: Determining Ideal Breastmilk Composition: What is the Gold Standard of Gold Standards

Denise Kelly
Investment Advisor
Seventure

Day Two

Thursday October 15, 2020

4:50 pm | Final Q&A and Discussion Panel

4:25 pm | Investing in Early Life Development- Priming Through the Microbiome

Dorottya Nagy-Szakal
Chief Medical Officer
Biotia, Inc.

Dorottya earned her MD and PhD in clinical medicine from Semmelweis University of Medicine in Hungary. Holding postdoctoral fellowships at Baylor College of Medicine/Texas Children's Hospital and Columbia University, she has 10+ years of experience in translational medicine, pediatrics, gastroenterology, microbiology and clinical metagenomics. She led cutting-edge clinical trials on fecal microbiome transplantation and developed a multicenter research program to understand the role of the gut-brain axis in the integrative neuroscience field. Currently, Dorottya is the Chief Medical Officer at Biotia, a NYC-based startup focusing on rapid infectious disease diagnostics, surveillance, and prevention of hospital acquired infections powered by artificial intelligence. 

Day Two

Thursday October 15, 2020

5:50 pm | Q&A and Discussion Panel

5:25 pm | Precision Infectious Disease Diagnostics in the Era of Next-Generation Sequencing (NGS) and Big Data

Erika Claud
Professor of Pediatrics
University of Chicago Medicine

Day Two

Thursday October 15, 2020

10:40 am | The Antibiotic Problem: Current and Future Opportunities When Treating Infants In the NICU

Fernanda Rosa
Postdoctoral Researcher
University of Arkansas for Medical Sciences

Day One

Wednesday October 14, 2020

5:15 pm | Wrap up Q&A and Panel

4:25 pm | Understanding the Impact of Human Milk on the Metabolome and Microbiome Using Animal Models

1:30 pm | Panel: Determining Ideal Breastmilk Composition: What is the Gold Standard of Gold Standards

Helen Vuong
Postdoctoral Fellow
University of California, Los Angeles

Day Two

Thursday October 15, 2020

3:45 pm | Q&A and Discussion Panel

3:20 pm | Using Mice to Understand the Role of the Maternal Microbiome in Nervous System Development and Behaviour

Janet Berrington
Consultant Neonatal Paediatrician
The Newcastle upon Tyne Hospitals

Day Two

Thursday October 15, 2020

10:40 am | The Antibiotic Problem: Current and Future Opportunities When Treating Infants In the NICU

Josef Neu
Professor, Department of Pediatrics
University of Florida

Day Two

Thursday October 15, 2020

10:40 am | The Antibiotic Problem: Current and Future Opportunities When Treating Infants In the NICU

Liza Konnikova
Assistant Professor
Yale University School of Medicine

Day One

Wednesday October 14, 2020

9:45 am | Joint Q&A and Discussion Panel

9:20 am | How Did That Get There? The In-Utero Intestine and Unique Metabolomic Presence

Lorenzo Corsini
Co-Founder & CEO
PhagoMed

Day One

Wednesday October 14, 2020

12:15 pm | Midday Q&A and Discussion Panel

11:50 am | Precision Vaginome Editing: The Use of Specific Endolysins for the Treatment of Bacterial Vaginosis

Mara Couto-Rodriguez
Director of R&D
Biotia

Day One

Wednesday October 14, 2020

12:15 pm | Midday Q&A and Discussion Panel

11:25 am | Precision Medicine Strategies Using NGS and AI in Women’s Health

Mary Claire Kimmel
Assistant Professor & Co-Director Perinatal Psychiatry Program
UNC School of Medicine

Day One

Wednesday October 14, 2020

9:45 am | Joint Q&A and Discussion Panel

8:30 am | Microbiome Reflections of Pregnancy: Prediction of Maternal and Infant Emotional Regulation

Meghan Azad
Associate Professor (Pediatrics and Child Health)
University of Manitoba

Day One

Wednesday October 14, 2020

3:50 pm | Afternoon Q&A and Panel

3:25 pm | Infant Feeding Practices and the Nasal Microbiome: New Findings From the CHILD Cohort Study

Nikole Kimes
Chief Executive Officer & Co-founder
Siolta Therapeutics

Day Two

Thursday October 15, 2020

11:30 am | The Path to Prevention: Siolta Therapeutics’ Allergic Disease Onset Reduction Study – ADORED

Petter Brodin
Associate professor of Immunology
Karolinska Institutet

Day Two

Thursday October 15, 2020

12:50 pm | Q&A and Extended Metabolic Disease Discussion Panel

12:00 pm | Bifidobacteria-Mediated Immune System Imprinting Early in Life

Priscilla Samuel, PhD
Chief Scientific Officer
Blue California Co.

Day One

Wednesday October 14, 2020

3:00 pm | Disruptive Technologies that Enable New Ingredients in Support of Infant Health & Well-being

3:50 pm | Afternoon Q&A and Panel

Siobhain O’Mahony
Senior Lecturer
University of Cork

Day One

Wednesday October 14, 2020

9:45 am | Joint Q&A and Discussion Panel

8:55 am | Maternal Gut Health: The Impacts of Stress On the Maternal/Infant Dyad

Stacy Kahn
Director, FMT and Microbial Therapeutics Program & Attending Physician, Inflammatory Bowel Disease Center
Boston Children’s Hospital

Day Two

Thursday October 15, 2020

9:45 am | Morning Q&A and Discussion Panel

9:20 am | The Latest Work on FMT and Treatment for Colitis

Tal Korem
Assistant Professor, Department of Systems Biology
Columbia University

Day One

Wednesday October 14, 2020

12:15 pm | Midday Q&A and Discussion Panel

11:00 am | The Vaginal Microbiome and Metabolome in Spontaneous Preterm Birth

Victoria Niklas
Global Program Leader
Takeda

Day Two

Thursday October 15, 2020

6:00 pm | Chair’s Closing remarks

8:20 am | Chair’s Opening Remarks